13F

AVNS AVANOS MEDICAL INC

2026Q1 · CUSIP 05350V106 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
254
Δ holders QoQ
-18
Breadth percentile
Top 91%
Whale holders
117
Δ whales
-3
Inst. holding value
$627M
New positions
30
Closed positions
48
Price momentum (1Q)
+65.9%
Put / Call
0/1

Breadth history (34 quarters)

2018Q1: Δ+0 · h=2 2018Q2: Δ+34 · h=36 2018Q3: Δ+339 · h=375 2018Q4: Δ-34 · h=341 2019Q1: Δ-10 · h=331 2019Q2: Δ-20 · h=311 2019Q3: Δ-27 · h=284 2019Q4: Δ+0 · h=284 2020Q1: Δ-17 · h=267 2020Q2: Δ+6 · h=273 2020Q3: Δ-2 · h=271 2020Q4: Δ+5 · h=276 2021Q1: Δ+9 · h=285 2021Q2: Δ-13 · h=272 2021Q3: Δ-3 · h=269 2021Q4: Δ+25 · h=294 2022Q1: Δ+2 · h=296 2022Q2: Δ-13 · h=283 2022Q3: Δ-12 · h=271 2022Q4: Δ+15 · h=286 2023Q1: Δ+0 · h=286 2023Q2: Δ-15 · h=271 2023Q3: Δ-14 · h=257 2023Q4: Δ+6 · h=263 2024Q1: Δ-2 · h=261 2024Q2: Δ-4 · h=257 2024Q3: Δ+1 · h=258 2024Q4: Δ+0 · h=258 2025Q1: Δ+18 · h=276 2025Q2: Δ+12 · h=288 2025Q3: Δ-11 · h=277 2025Q4: Δ-5 · h=272 2026Q1: Δ-18 · h=254 2018Q1: holders=2 2018Q2: holders=36 2018Q3: holders=375 2018Q4: holders=341 2019Q1: holders=331 2019Q2: holders=311 2019Q3: holders=284 2019Q4: holders=284 2020Q1: holders=267 2020Q2: holders=273 2020Q3: holders=271 2020Q4: holders=276 2021Q1: holders=285 2021Q2: holders=272 2021Q3: holders=269 2021Q4: holders=294 2022Q1: holders=296 2022Q2: holders=283 2022Q3: holders=271 2022Q4: holders=286 2023Q1: holders=286 2023Q2: holders=271 2023Q3: holders=257 2023Q4: holders=263 2024Q1: holders=261 2024Q2: holders=257 2024Q3: holders=258 2024Q4: holders=258 2025Q1: holders=276 2025Q2: holders=288 2025Q3: holders=277 2025Q4: holders=272 2026Q1: holders=254 -339 -169.5 +0 +169.5 +339 1198394 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 4 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 13% -12.0% -14.4%
2021Q4 Top 19% -9.1% -12.0%
2018Q3 Top 0% +2.8% -12.6%
2018Q2 Top 5%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
1
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-1.60
EPS YoY
Revenue (TTM)
$0.7B
Revenue YoY
+3.9%
Quarterly Revenue & EPS (4Y)
2022-06-30: $171M 2022-09-30: $172M 2022-12-31: $144M 2023-03-31: $159M 2023-06-30: $169M 2023-09-30: $171M 2023-12-31: $173M 2024-03-31: $166M 2024-06-30: $172M 2024-09-30: $170M 2024-12-31: $180M 2025-03-31: $168M 2025-06-30: $175M 2025-09-30: $178M 2025-12-31: $181M 2026-03-31: $182M 2022-06-30: EPS 0.26 2022-09-30: EPS 0.33 2022-12-31: EPS 0.37 2023-03-31: EPS -0.01 2023-06-30: EPS -1.46 2023-09-30: EPS -0.08 2023-12-31: EPS 0.23 2024-03-31: EPS -0.02 2024-06-30: EPS 0.04 2024-09-30: EPS 0.09 2024-12-31: EPS -8.64 2025-03-31: EPS 0.14 2025-06-30: EPS -1.66 2025-09-30: EPS -0.03 2025-12-31: EPS -0.02 2026-03-31: EPS 0.11 0M 91M 182M $M -9.50 -4.55 0.41 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 55 2023-03-31: PE 23.92024-06-30: PE 137.22024-09-30: PE 54.9 22 83 144 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)